Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery
Disease Category: Skin Infections/Disorders

Trial Information

Severe Chronic Hidradenitis Suppurativa - Adults

Adults with Severe Chronic Hidradenitis Suppurativa are asked to participate in a research study being conducted by New York University School of Medicine.

You may be eligible to participate in this study if:

• You are at least 18 years of age
• You have a diagnosis of HS for at least 6 months (180 days) and on at least two areas of your body
• Oral (by mouth) antibiotics for treatment of your HS have not worked for you
• You have stable HS for at least 2 months (60 days) before the study start-up visits

You may not participate in this study if you:

• Have had prior treatment with adalimumab or other (e.g. infliximab or etanercept) anti-TNF therapy, or participation in an adalimumab trial
• Have any active skin disease or condition (e.g., bacterial, fungal or viral infection) that may interfere with evaluating your hidradentis suppurativa
• Have used Tysabri® (natalizumab);
• Have a history of drug or alcohol abuse in the last 12 months

Elizabeth Camacho, Study Coordinator
Biomedical Research Alliance of New York
NYU School of Medicine
560 1st Avenue
New York, NY 10016
Phone: 212-263-5244
EMail: dermpharm@med.nyu.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.